mirtazapine has been researched along with Melanoma in 2 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Puzik, A | 1 |
Möller, J | 1 |
Meiss, F | 1 |
Kontny, U | 1 |
Rössler, J | 1 |
Uzawa, K | 1 |
Kasamatsu, A | 1 |
Shimizu, T | 1 |
Saito, Y | 1 |
Baba, T | 1 |
Sakuma, K | 1 |
Fushimi, K | 1 |
Sakamoto, Y | 1 |
Ogawara, K | 1 |
Shiiba, M | 1 |
Tanzawa, H | 1 |
2 other studies available for mirtazapine and Melanoma
Article | Year |
---|---|
Side effects of interferon therapy in adolescent melanoma.
Topics: Adolescent; Adrenergic alpha-Antagonists; Depression; Humans; Immunologic Factors; Interferon-alpha; | 2014 |
Suppression of metastasis by mirtazapine via restoration of the Lin-7C/β-catenin pathway in human cancer cells.
Topics: Adrenergic alpha-Antagonists; Animals; beta Catenin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cel | 2014 |